search
close_mark

Stef Schutte

Stef Schutte

02 Dec, 2025

With 30+ years in pharma, Stef has led global Regulatory Affairs at Astellas and served as Head of RA-EMEA at Merck (MSD), advancing development, approvals, and compliance across international markets.

Extensive experience in strengthening regulatory operations, accelerating product development pathways, and building high-performing teams.

Cheryl Jessen
Read Now

Other Related Articles

PMCF Under MDR: When is a Healthcare Professional Survey Approach Justifiable?
Blog Medical Devices

PMCF Under MDR: When is a Healthcare Professional Survey Approach Justifiable?

29 Apr, 2026

Dental Medical Devices: Special Considerations for Clinical Evaluation Under EU MDR
Blog Medical Devices

Dental Medical Devices: Special Considerations for Clinical Evaluation Under EU MDR

22 Apr, 2026

MDR Article 117: What It Means — And How We Help You Get Ahead
Blog Medical Devices

MDR Article 117: What It Means — And How We Help You Get Ahead

16 Apr, 2026

Heavy Metals in Pharmaceuticals: A Critical Quality and Safety Imperative
Blog Pharmaceutical

Heavy Metals in Pharmaceuticals: A Critical Quality and Safety Imperative

10 Apr, 2026

EMA Roadmap Update: PMS Capabilities and the End of the Legacy Era
Blog Pharmaceutical

EMA Roadmap Update: PMS Capabilities and the End of the Legacy Era

01 Apr, 2026

Expanded Access Approval : Balancing Urgency and Oversight in Regulatory Affairs
Blog Pharmaceutical

Expanded Access Approval : Balancing Urgency and Oversight in Regulatory Affairs

26 Mar, 2026

How to Reduce Notified Body Review Cycles Through Better Clinical Documentation
Blog Medical Devices

How to Reduce Notified Body Review Cycles Through Better Clinical Documentation

18 Mar, 2026

The Great Convergence — Why 2026 is the Year Regulatory “Records” Die
Blog Pharmaceutical

The Great Convergence — Why 2026 is the Year Regulatory “Records” Die

10 Mar, 2026

View All